Safety and tolerability of a new oral supplement
This study tests a new oral product to see if it is safe and well-tolerated in healthy adults and children. It requires a 7-day stay at a research facility.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Healthy adults aged 18 to 60 years, or children over 3 to 18 years
- Must be willing to stay at the research clinic for 7 days
- No diarrhea or other illness in the past 2 weeks
- No use of antibiotics (for children) or laxatives (for adults) recently
- Must not have hepatitis B or C
- Must not be pregnant or breastfeeding (for women)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine in healthy people to see if it is safe and how the body handles it. Participating could help understand side effects before testing in patients.
This early-stage study tests a new experimental drug called LG-0317 in healthy volunteers to see if it is safe and how the body processes it. If you are healthy and meet the basic requirements, this trial may help advance a new treatment option.
This study tests a new investigational medicine in healthy adults to see how safe it is and how the body processes it. It is a first-in-human trial, so it is looking for volunteers who are generally well and have normal immune function.
This study tests a new medicine called BLX-7006 in healthy adults to see if it is safe and to learn how the body handles it. Participating could help decide if the drug should be tested in people with certain conditions later.
This is a Phase 1 safety study testing a new investigational drug in healthy volunteers with no serious medical conditions. Researchers will give some participants the drug and others a placebo (inactive treatment) to see how safe the drug is and how the body responds to it.
This is a first-in-human study to test an investigational drug called PSTB100 in healthy adults. The purpose is to see how the body handles the drug and to check for any side effects. Participation may help with future treatment development.
Hear when a new Safety and Tolerability in Healthy Volunteers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.